{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:01:00Z","timestamp":1793088060236,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE) may occasionally show similar cytological and biochemical picture including ADA. In such cases, differentiating TPE and MPE is challenging and needs histopathology of pleural tissue which may involve invasive procedures. The present study aims to evaluate the diagnostic accuracy of pleural fluid ADA to serum CRP (ADA\/CRP) ratio to discriminate between tuberculous and malignant pleural effusion. In addition, we investigated whether the ratio ADA\/CRP adds diagnostic value to ADA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study was conducted in the National Institute of Diseases of the Chest and Hospital (NIDCH), Mohakhali, Dhaka, from July 2021 to February 2022 on diagnosed patients of TPE and malignant pleural effusion MPE. A receiver operating characteristic curve (ROC) was constructed for identifying TPE. The added value of the ADA\/CRP ratio to ADA was evaluated using the net reclassification improvement (NRI) and integrated discrimination improvement (IDI). A value of<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 was considered statistically significant for all tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-nine patients were enrolled in this study, of which 31 had TPE, and 28 had MPE. Pleural fluid ADA to serum CRP ratio and pleural fluid ADA level was significantly higher in patients with TPE, but there was no significant difference in serum CRP levels between patients with TPE and MPE. At cut off value of\u2009&gt;\u20091.25, pleural fluid ADA to serum CRP ratio had a sensitivity of 93.8%, specificity of 85.2%, and positive and negative predictive values were 88.2% and 92% respectively, in the diagnosis of TPE and area under ROC curve (AUC) was 0.94. The NRI and IDI analyses revealed added diagnostic value of ADA\/CRP to ADA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study shows that the ADA\/CRP ratio improves the diagnostic usefulness of ADA for TPE.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12890-023-02644-9","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:01:54Z","timestamp":1694779314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion"],"prefix":"10.1186","volume":"23","author":[{"given":"Mohammad Fazle","family":"Rabbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushfiq Newaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shafiqul Alam","family":"Patowary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Rezaul","family":"Huq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M. Abdur","family":"Razzaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossain Md.","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnuva","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Azmain","family":"Iktidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"2644_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.mcna.2011.08.005","volume":"95","author":"RW Light","year":"2011","unstructured":"Light RW. Pleural effusions. Med Clin North Am. 2011;95:1055\u201370.","journal-title":"Med Clin North Am"},{"key":"2644_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ccm.2005.12.004","volume":"27","author":"SA Sahn","year":"2006","unstructured":"Sahn SA. Pleural effusions of extravascular origin. Clin Chest Med. 2006;27:285\u2013308.","journal-title":"Clin Chest Med"},{"key":"2644_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MAJ.0b013e31815d25e6","volume":"335","author":"SA Sahn","year":"2008","unstructured":"Sahn SA. The value of pleural fluid analysis. Am J Med Sci. 2008;335:7\u201315.","journal-title":"Am J Med Sci"},{"key":"2644_CR4","doi-asserted-by":"crossref","unstructured":"Light RW. Pleural effusion. N Engl J Med. 2002;346:1971\u20137.","DOI":"10.1056\/NEJMcp010731"},{"key":"2644_CR5","unstructured":"World Health Organization. Global Tuberculosis Report 2021. Geneva; 2021."},{"key":"2644_CR6","doi-asserted-by":"crossref","unstructured":"Escudero Bueno C, Garcia Clemente M, Cuestra Castro B, Molinos Martin L, Rodriguez Ramos S, Gonzalez Panizo A, et al. Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope\u2019s needle. Study of 414 patients. Arch Intern Med. 1990;150:1190\u20134.","DOI":"10.1001\/archinte.150.6.1190"},{"key":"2644_CR7","doi-asserted-by":"crossref","unstructured":"Chapman SJ, Robinson G, Shrimanker R, Turnbull CD, Wrightson JM. Oxford Handbook of Respiratory Medicine. 4th edition. Oxford: Oxford University Press; 2021.","DOI":"10.1093\/med\/9780198837114.001.0001"},{"key":"2644_CR8","doi-asserted-by":"crossref","unstructured":"Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis. PLoS One. 2021;16:e0253525.","DOI":"10.1371\/journal.pone.0253525"},{"key":"2644_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00408-016-9891-2","volume":"194","author":"RM Terra","year":"2016","unstructured":"Terra RM, Antonangelo L, Mariani AW, de Oliveira RLM, Teixeira LR, Pego-Fernandes PM. Pleural Fluid Adenosine Deaminase (ADA) predicts survival in patients with malignant pleural effusion. Lung. 2016;194:681\u20136.","journal-title":"Lung"},{"key":"2644_CR10","first-page":"259","volume":"65","author":"Y Ogat","year":"2011","unstructured":"Ogat Y, Aoe K, Hiraki A, Murakami K, Kishino D, Chikamori K, et al. Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis? Acta Med Okayama. 2011;65:259\u201363.","journal-title":"Acta Med Okayama"},{"key":"2644_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.21037\/atm.2019.09.110","volume":"8","author":"M Zhang","year":"2020","unstructured":"Zhang M, Li D, Hu Z-D, Huang Y-L. The diagnostic utility of pleural markers for tuberculosis pleural effusion. Ann Transl Med. 2020;8:607\u2013607.","journal-title":"Ann Transl Med"},{"key":"2644_CR12","first-page":"237","volume":"65","author":"SM Nehring","year":"2023","unstructured":"Nehring SM, Goyal A, Bansal P, Patel BC. C Reactive protein. StatPearls. 2023;65:237\u201344.","journal-title":"StatPearls"},{"key":"2644_CR13","volume":"63","author":"A Landry","year":"2017","unstructured":"Landry A, Docherty P, Ouellette S, Cartier LJ. Causes and outcomes of markedly elevated C-reactive protein levels. Can Fam Physician. 2017;63: e316.","journal-title":"Can Fam Physician"},{"key":"2644_CR14","unstructured":"Swetha B, Vijaya Kumar KV V, Kundan Raja J, Suryakumari V, Padmaja B. Utility of Pleural fluid ADA: Serum CRP ratio in diagnosing. IOSR J Dent Med Sci (IOSR-JDMS) e-ISSN. 2020;19:19\u201325."},{"key":"2644_CR15","doi-asserted-by":"crossref","unstructured":"Venkatesh V, B S, J K. Utility of Pleural Fluid ADA: Serum CRP ratio in diagnosing malignant and tuberculous pleural effusion. Chest. 2020;157:A197.","DOI":"10.1016\/j.chest.2020.05.221"},{"key":"2644_CR16","doi-asserted-by":"crossref","unstructured":"Buderer NMF. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3:895\u2013900.","DOI":"10.1111\/j.1553-2712.1996.tb03538.x"},{"key":"2644_CR17","first-page":"191","volume-title":"Textbook of pleural diseases","author":"S Sahn","year":"2003","unstructured":"Sahn S, Heffner J. Pleural fluid analysis. In: Light R, Lee Y, editors. Textbook of pleural diseases. London: Arnold; 2003. p. 191\u2013209."},{"key":"2644_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1037\/pha0000258","volume":"27","author":"MJ De Vita","year":"2019","unstructured":"De Vita MJ, Maisto SA, Ansell EB, Zale EL, Ditre JW. Pack-years of tobacco cigarette smoking as a predictor of spontaneous pain reporting and experimental pain reactivity. Exp Clin Psychopharmacol. 2019;27:552\u201360.","journal-title":"Exp Clin Psychopharmacol"},{"key":"2644_CR19","unstructured":"National Center for Health Statistics. National Health Interview Survey, sample adult core component. 2019."},{"key":"2644_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB, D\u2019Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157\u201372.","journal-title":"Stat Med"},{"key":"2644_CR21","first-page":"351","volume":"2015","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, STARD, et al. an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;2015:351.","journal-title":"BMJ"},{"key":"2644_CR22","first-page":"132","volume":"5","author":"MTA Kadhim","year":"2021","unstructured":"Kadhim MTA, Hashim HM. The pleural fluid lactate dehydrogenase \/adenosine deaminase and pleural fluid adenosine deaminase \/serum C-Reactive Protein ratios for differentiating between Tuberculosis and other causes in a sample of Iraqi patients. Iraq Med J. 2021;5:132\u20135.","journal-title":"Iraq Med J"},{"key":"2644_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clinbiochem.2004.09.023","volume":"38","author":"D Ernam","year":"2005","unstructured":"Ernam D, Atalay F, Hasanoglu HC, Kaplan \u00d6. Role of biochemical tests in the diagnosis of exudative pleural effusions. Clin Biochem. 2005;38:19\u201323.","journal-title":"Clin Biochem"},{"key":"2644_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ejim.2010.03.011","volume":"21","author":"JM Porcel","year":"2010","unstructured":"Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med. 2010;21:419\u201323.","journal-title":"Eur J Intern Med"},{"key":"2644_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00408-008-9085-7","volume":"186","author":"B Zari\u0107","year":"2008","unstructured":"Zari\u0107 B, Kuruc V, Milovan\u010dev A, Markovic M, \u0160ar\u010dev T, \u010canak V, et al. Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase? Lung. 2008;186:233\u201340.","journal-title":"Lung"},{"key":"2644_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1373\/clinchem.2012.182550","volume":"58","author":"KGM Moons","year":"2012","unstructured":"Moons KGM, De Groot JAH, Linnet K, Reitsma JBR, Bossuyt PMM. Quantifying the added value of a diagnostic test or marker. Clin Chem. 2012;58:1408\u201317.","journal-title":"Clin Chem"},{"key":"2644_CR27","unstructured":"National Tuberculosis Control Programme (NTP). National Guideline and Operational Manual for Tuberculosis. Dhaka: Directorate General of Health Services, Bangladesh; 2021."}],"updated-by":[{"DOI":"10.1186\/s12890-023-02694-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000}}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02644-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02644-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02644-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T04:38:50Z","timestamp":1730090330000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02644-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2644"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02644-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been corrected since original publication; please see the linked erratum for further details.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12890-023-02694-z","URL":"https:\/\/doi.org\/10.1186\/s12890-023-02694-z","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of National Institute of Diseases of the Chest and Hospital (NIDCH), Mohakhali, Dhaka, Bangladesh (e-registration no: 17111821503) and adhered to the 1975 Declaration of Helsinki's ethical criteria (6th version, 2008), as shown in a priori approval by the institutional review committee. Written informed consent was obtained from all the participants\/participants' guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"349"}}